CORE LABORATORIES N V 4
4 · CORE LABORATORIES N V · Filed Jan 4, 2016
Insider Transaction Report
Form 4
BERGMARK RICHARD L
DirectorEVP, CFO & Treasurer
Transactions
- Exercise/Conversion
Restricted Performance Shares
2015-12-31−11,721→ 0 totalExercise: $0.00→ Common Shares (11,721 underlying) - Exercise/Conversion
Common Shares
2015-12-31+11,721→ 71,656 total - Tax Payment
Common Shares
2015-12-31$108.74/sh−3,579$389,180→ 68,077 total
Holdings
- 69,802(indirect: By 401(k))
Common Shares
Footnotes (1)
- [F1]The shares vesting were awarded as restricted performance shares in February 2013. As reported in the Form 4 filing on February 15, 2013 at the time the award was made, "The restricted performance shares will vest only upon the Company's return on invested capital being in the top decile of the Company's peers as published by Bloomberg upon the close of the NYSE market on the last day of the Performance Period and the shares shall fully vest if that criterion is met. If it is not met, then no shares shall vest and the award shall be forfeited." The performance criteria and all requirements for vesting have been met and thus the shares fully vested on December 31, 2015, at the conclusion of the performance period.